Structural signature of the G719S-T790M double mutation in the EGFR kinase domain and its response to inhibitors

George Priya Doss C.*, Rajith B., Chiranjib Chakraborty, NagaSundaram N., Shabana Kouser Ali, Hailong Zhu*

*Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

43 Citations (Scopus)


Some individuals with non-small-cell lung cancer (NSCLC) benefit from therapies targeting epidermal growth factor receptor (EGFR), and the characterization of a new mechanism of resistance to the EGFR-specific antibody gefitinib will provide valuable insight into how therapeutic strategies might be designed to overcome this particular resistance mechanism. The G719S and T790M mutations and their combination were involved in causing different conformational redistribution of EGFR. In the present computational study, we analyzed the impact and structural influence of G719S/T790M double mutation (DM) in EGFR with ligand (gefitinib) through molecular dynamic simulation (50â €..ns) and docking analysis. We observed the escalation in distance between the functional loop and activation loop with respect to T790M mutation compared to the G719S mutation. Furthermore, we confirmed that the G719S mutation causes the ligand to move closer to the hinge region, whereas T790M makes the ligand escape from the binding pocket. Obtained results provide with an explanation for the resistance induced by T790M and a vital clue for the design of drugs to combat gefitinib resistance.

Original languageEnglish
Article number5868
Number of pages7
JournalScientific Reports
Publication statusPublished - 5 Aug 2014

Scopus Subject Areas

  • General


Dive into the research topics of 'Structural signature of the G719S-T790M double mutation in the EGFR kinase domain and its response to inhibitors'. Together they form a unique fingerprint.

Cite this